PO
Therapeutic Areas
PolyNovo Pipeline
| Drug | Indication | Phase |
|---|---|---|
| NovoSorb BTM | Complex Wound Reconstruction (Trauma, Burns) | Approved/Commercial |
| NovoSorb MTX | Hernia Repair | Approved/Commercial |
| NovoSorb Polymer | Cardiovascular Patches | Research & Development |
Leadership Team at PolyNovo
DW
David Williams
Chief Executive Officer (CEO) & Managing Director
SR
Swami Raote
Chief Financial Officer (CFO)
DC
Dr. Chandan K. Sen
Former Chief Science Officer (CSO) / Scientific Advisor
SN
Scott N. Johnson
General Manager, Americas
IM
Ian McAllister
Non-Executive Chairman
DM
Dr. Marie-Alda Gilles
Non-Executive Director